Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences

A Aiello, S Najafi-Fard, D Goletti - Frontiers in Immunology, 2023 - frontiersin.org
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) and Coronavirus disease-
2019 (COVID-19), whose etiologic agent is severe acute respiratory syndrome coronavirus …

Immune interaction between SARS-CoV-2 and Mycobacterium tuberculosis

P Booysen, KA Wilkinson, D Sheerin, R Waters… - Frontiers in …, 2023 - frontiersin.org
SARS-CoV-2 and Mycobacterium tuberculosis (Mtb) are major infectious causes of death,
with meta-analyses and population-based studies finding increased mortality in co-infected …

The COVID-19, tuberculosis and HIV/AIDS: Ménage à Trois

AJ Udoakang, AL Djomkam Zune, K Tapela… - Frontiers in …, 2023 - frontiersin.org
In December 2019, a novel pneumonic condition, Coronavirus disease 2019 (COVID-19)
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), broke out in …

Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection

JA Shaw, ST Malherbe, G Walzl… - Frontiers in …, 2023 - frontiersin.org
Epidemiologic data show that both current and previous tuberculosis (TB) increase the risk
of in-hospital mortality from coronavirus disease-2019 (COVID-19), and there is a similar …

The effect of previous SARS-CoV-2 infection on systemic immune responses in individuals with tuberculosis

MS Xavier, M Araujo-Pereira, QM De Oliveira… - Frontiers in …, 2024 - frontiersin.org
Background The impact of previous SARS-CoV-2 infection on the systemic immune
response during tuberculosis (TB) disease has not been explored. Methods An …

Prevalence of indeterminate tuberculosis interferon‐gamma release assays in COVID‐19 patients: Systematic review and meta‐analysis

A Ben Tekaya, A Jerbi, M Ben Sassi… - Health Science …, 2023 - Wiley Online Library
Abstract Background and Aims The reliability of interferon‐gamma‐release‐assays (IGRAs)
for tuberculosis (TB) testing in coronavirus disease 2019 (COVID‐19) patients is unknown …

Distinct and overlapping immunological responses to SARS-CoV-2 and Mycobacterium tuberculosis identified by single-cell RNA-seq of co-infected whole blood

D Sheerin, TK Phan, EM Eriksson… - medRxiv, 2023 - medrxiv.org
Introduction COVID-19 and tuberculosis (TB) exhibit similar symptomatic presentation and
clinical parameters. Common underlying immunological mechanisms also highlight …

Diverse interactions of Mycobacterium tuberculosis infection and of BCG vaccination with SARS-CoV-2

P Salgame, SR Pentakota, JCM Malabad… - Frontiers in …, 2024 - frontiersin.org
The COVID pandemic and tuberculosis (TB) endemicity is double trouble to much of the
world. SARS-CoV-2 and Mycobacterium tuberculosis (Mtb), causative agents of COVID and …

TBC and COVID: an interplay between two infections

G Murdaca, F Paladin, G Mangini, D Tiso… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction In a historical era dominated by the SARS-CoV-2 pandemic, a fact of growing
interest emerges regarding co-infection with Mycobacterium tuberculosis (M. tuberculosis) …

Antibody Responses to SARS-CoV-2 in a large university setting and in context of Mycobacterium tuberculosis infected animals

MR Merling - 2024 - search.proquest.com
Severe acute respiratory syndrome associated coronavirus 2 (SARS-CoV-2) infected,
asymptomatic individuals are an important contributor to Coronavirus Disease 2019 (COVID …